EGIS-12,233 is a drug with applications in scientific research, acting as a potent and selective antagonist for both the 5-HT6 and 5-HT7 serotonin receptor subtypes, with good selectivity over other receptors.[1] It has been shown to increase dopamine release in cochlear tissue, suggesting a role for the 5-HT6 and 5-HT7 receptors in regulation of the hearing system.[2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
PubChem CID |
|
Chemical and physical data | |
Formula | C24H28Cl3N3O |
Molar mass | 480.86 g·mol−1 |
3D model (JSmol) |
|
| |
(verify) |